Efficacy and Safety of Intralesional Platelet-Rich Plasma Compared to 5% Topical Minoxidil in the Treatment of Male Androgenetic Alopecia Affecting the Vertex

A 22-year-old has been using dutasteride, oral minoxidil, platelet-rich plasma therapy, and low-level laser therapy for hair loss but is still experiencing progression from Norwood 2 to 3. Others suggest increasing dutasteride dosage or trying additional treatments like RU58841 or topical finasteride.

The conversation discusses alternatives to Platelet-rich plasma (PRP) for treating androgenic alopecia. Treatments mentioned include Minoxidil, finasteride, and RU58841.

A woman with androgenetic alopecia is using a treatment of topical finasteride with 7% minoxidil, spironolactone, and supplements like iron, vitamin D, biotin, and zinc. She is considering additional treatments like PRP and laser therapy but has not seen significant hair regrowth yet.

A 33-year-old male is documenting his hair regrowth progress using minoxidil, red light therapy, copper peptides, and micro-needling, with noticeable improvement in hair thickness and coverage. He plans to add a topical finasteride/minoxidil spray and aims for a shadow on his scalp rather than a full head of hair.

The user is using a combination of finasteride, minoxidil, ketoconazole, pumpkin seeds, laser therapy, PRP, dermaroller, and vitamins for hair loss. They are advised to switch to oral finasteride and be patient, as results may take up to a year, with a hair transplant as a potential future option.

Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.